G01N 2800/387
Down syndrome
Official title: Down syndrome; Trisomy 18; Trisomy 13
G01N2800/387 (Down syndrome) appears on 76 US grants and 128 published applications in this corpus.
Search patents in G01N- Granted patents
- 76
- Published applications
- 128
- Assignees
- 69
- Inventors
- 179
- Latest grant
- 18 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 4 |
| 2004 | 1 | 2 |
| 2005 | 0 | 3 |
| 2006 | 0 | 4 |
| 2007 | 1 | 3 |
| 2008 | 2 | 4 |
| 2009 | 0 | 10 |
| 2010 | 2 | 8 |
| 2011 | 4 | 7 |
| 2012 | 6 | 9 |
| 2013 | 4 | 7 |
| 2014 | 7 | 11 |
| 2015 | 7 | 8 |
| 2016 | 2 | 4 |
| 2017 | 5 | 6 |
| 2018 | 2 | 8 |
| 2019 | 2 | 5 |
| 2020 | 7 | 3 |
| 2021 | 0 | 7 |
| 2022 | 2 | 2 |
| 2023 | 3 | 4 |
| 2024 | 5 | 2 |
| 2025 | 3 | 4 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Combinations of biomarkers for methods for detecting trisomy 2118 Nov 2025US 12,474,355 B2Rosetta Signaling Laboratories, LLC
- Determining a nucleic acid sequence imbalance associated with cancer using multiple markers18 Feb 2025US 12,227,804 B2The Chinese University of Hong Kong
- Preparation of fetal nucleated red blood cells (NRBCs) for diagnostic testing21 Jan 2025US 12,203,946 B2Kellbenx Incorporated
- Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing6 Aug 2024US 12,054,776 B2The Chinese University of Hong Kong
- Noninvasive diagnosis of fetal aneuploidy by sequencing6 Aug 2024US 12,054,777 B2The Board of Trustees of the Leland Standford Junior University
- Combinations of biomarkers for methods for detecting trisomy 215 Mar 2026US 2026/0063647 A1Rosetta Signaling Laboratories, LLC
- Process for detection of fetal cells5 Feb 2026US 2026/0036498 A1Menarini Silicon Biosystems S.p.A.
- Determining a nucleic acid sequence imbalance associated with cancer using multiple markers8 Jan 2026US 2026/0009078 A1The Chinese University of Hong Kong
- Preparation of fetal nucleated red blood cells (nrbcs) for diagnostic testing27 Nov 2025US 2025/0362313 A1Kellbenx Incorporated
- Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing16 Oct 2025US 2025/0320558 A1The Chinese University of Hong Kong
Most cited
By later US patents
- Noninvasive diagnosis of fetal aneuploidy by sequencing361US 8,195,415 B2The Board of Trustees of the Leland Stanford Junior University · 2012
- Noninvasive diagnosis of fetal aneuoploidy by sequencing193US 8,296,076 B2The Board of Trustees of the Leland Stanford Junior University · 2012
- Determining a nucleic acid sequence imbalance132US 8,706,422 B2The Chinese University of Hong Kong · 2014
- Antibodies specific for N-terminal truncated and pyroglutamate modified amyloid-beta peptides35US 8,058,405 B2Probiodrug AG · 2011
- Protofibril selective antibodies and the use thereof33US 8,025,878 B2BioArctic Neuroscience AB · 2011